🇪🇸 Spain · EU Public Tender
Suministro de medicamentos biológicos originales y biosimilares basadas en los principios activos adalimumab, trastuzumab, etanercept, rituximab, infliximab y bevacizumab para el Hospital Universitario Miguel Servet de Zaragoza
🏛️ Gerencia Sector Sanitario de Zaragoza 2 · 📍 Zaragoza
2.1M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | ABBVIE SPAIN, S.L.U |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.